Overview

The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The SCORE Study will compare the effectiveness and safety of standard care to intravitreal injection(s) of triamcinolone for treating macular edema (swelling of the central part of the retina) associated with central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO).
Phase:
Phase 3
Details
Lead Sponsor:
The Emmes Company, LLC
The EMMES Corporation
Collaborators:
Allergan
National Eye Institute (NEI)
Treatments:
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide